Umc Using Hydroxychloroquine For Covid

Initiating stage 2 research in mechanically ventilated patients with severe COVID-19. Aprepitant (Cinvanti; Heron Therapeutics) is a compound P/neurokinin-1 receptor antagonist. Product P and its own receptor, NK1, are sent out throughout the body in the cells of many tissue and organs, like the lungs. Period 2 clinical study (GUARDS-1) initiated mid-July 2020 in early-hospitalized… Continue reading Umc Using Hydroxychloroquine For Covid